Google
×
REVLIMID is a prescription medicine, used to treat adults with multiple myeloma (MM) in combination with the medicine dexamethasone, or as maintenance treatment ...
People also ask
REVLIMID is indicated for the treatment of adult patients with transfusion-dependent anemia due to low- or intermediate-1-risk myelodysplastic syndromes (MDS) ...
It works by slowing or stopping the growth of cancer cells. It is also used to treat anemia in patients with certain blood/bone marrow disorders ( ...
REVLIMID in combination with dexamethasone is indicated for the treatment of patients with multiple myeloma (MM) who have received at least one prior therapy.
Revlimid® (lenalidomida) em terapia combinada ... Revlimid® (lenalidomida), em combinação com ... informações de bula do produto. Não surgiram ...
Jan 31, 2024 · Description. Lenalidomide is used to treat anemia (low red blood cells) in patients with a certain type of myelodysplastic syndrome (MDS).
Dosing & Uses ; Treatment · Dexamethasone schedule ; Thrombocytopenia within 4 weeks at starting dose 10 mg/day. Baseline ≥100,000/mcL ; Thrombocytopenia after 4 ...
Revlimid in combination with dexamethasone is indicated for the treatment of multiple myeloma in adult patients who have received at least one prior therapy.
Apr 22, 2024 · Revlimid is a medication used to treat types of multiple myeloma, mantle cell lymphoma, follicular lymphoma, marginal zone lymphoma, ...
The standard treatment dose for Revlimid is one 25 mg capsule each day for 21 days of a 28-day Cycle. Your physician may consider reducing the dose because of ...